Co-Diagnostics Inc (CODX) seems to be a strong buy
Co-Diagnostics Inc (CODX) currently trades at $8.00 and has grown by 7.24% today. CODX said Monday that it achieved several milestones in 2019 by strengthening its strategic relationships and product pipeline which have set the company up for further growth in 2020.
Based on this information, investorsQ rates this stock 5 out of 10. We give it this rating based on current information such as the company reported financial results for the year to December 2019, the Salt Lake City-based molecular diagnostics group noted that it had been the first US company to receive a CE-mark from the European Union (EU) for its Logix Smart coronavirus (COVID-19) test. The high forecast for Co-Diagnostics Inc is $20.00 and the low is $5.00. Notably, the company’s market cap is $221.16 million with a 52 week high of $21.75 and a 52 week low of $0.69.